Lupin is currently trading at Rs. 853.25, up by 0.85 points or 0.10% from its previous closing of Rs. 852.40 on the BSE.
The scrip opened at Rs. 850.00 and has touched a high and low of Rs. 859.50 and Rs. 848.45 respectively. So far 36712 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 986.00 on 10-Sep-2018 and a 52 week low of Rs. 723.55 on 15-May-2018.
Last one week high and low of the scrip stood at Rs. 864.15 and Rs. 838.55 respectively. The current market cap of the company is Rs. 38657.02 crore.
The promoters holding in the company stood at 47.00%, while Institutions and Non-Institutions held 37.69% and 15.30% respectively.
Lupin’s US subsidiary, Lupin Pharmaceuticals Inc is recalling 6,752 bottles of Testosterone Topical solution in the strength of 30mg/1.5mL from the American market on account of defective container. The product is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone. The reason for recall is Defective Container Repetitive complaints received indicating pump not working.
Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.
